Cofactor regulation of C5a chemotactic activity in physiological fluids. Requirement for the vitamin D binding protein, thrombospondin-1 and its receptors.
Factors in physiological fluids that regulate the chemotactic activity of complement activation peptides C5a and C5a des Arg are not well understood. The vitamin D binding protein (DBP) has been shown to significantly enhance chemotaxis to C5a/C5a des Arg. More recently, platelet-derived thrombospondin-1 (TSP-1) has been shown to facilitate the augmentation of C5a-induced chemotaxis by DBP. The objective of this study was to better characterize these chemotactic cofactors and investigate the role that cell surface TSP-1 receptors CD36 and CD47 may play in this process. The chemotactic activity in C-activated normal serum, citrated plasma, DBP-depleted serum or C5 depleted serum was determined for both normal human neutrophils and U937 cell line transfected with the C5a receptor (U937-C5aR). In addition, levels of C5a des Arg, DBP and TSP-1 in these fluids were measured by RIA or ELISA. Results show that there is a clear hierarchy with C5a being the essential primary signal (DBP or TSP-1 will not function in the absence of C5a), DBP the necessary cofactor and TSP-1 a dependent tertiary factor, since it cannot function to enhance chemotaxis to C5a without DBP. Measurement of the C5a-induced intracellular calcium flux confirmed the same hierarchy observed with chemotaxis. Moreover, analysis of bronchoalveolar lavage fluid (BALF) from patients with the adult respiratory distress syndrome (ARDS) demonstrated that C5a-dependent chemotactic activity is significantly decreased after anti-DBP treatment. Finally, results show that TSP-1 utilizes cell surface receptors CD36 and CD47 to augment chemotaxis, but DBP does not bind to TSP-1, CD36 or CD47. The results clearly demonstrate that C5a/C5a des Arg needs both DBP and TSP-1 for maximal chemotactic activity and suggest that the regulation of C5a chemotactic activity in physiological fluids is more complex than previously thought.
Department of Pathology, Stony Brook University School of Medicine, Stony Brook, NY 11794-8691, USA.
Glenda
G
Trujillo
Jianhua
J
Zhang
David M
DM
Habiel
Lingyin
L
Ge
Mahalakshmi
M
Ramadass
Berhane
B
Ghebrehiwet
Richard R
RR
Kew
D018955:CD36 Antigens / Q000276:immunology; D051928:CD47 Antigen / Q000097:blood / Q000276:immunology*; D045744:Cell Line, Tumor; D002633:Chemotaxis; D015936:Complement C5a / Q000037:antagonists & inhibitors / Q000276:immunology*; D006801:Humans; D008024:Ligands; D011485:Protein Binding; D019700:Thrombospondin 1 / Q000097:blood / Q000276:immunology*
D018955:CD36 Antigens; D051928:CD47 Antigen; C497894:CD47 protein, human; D008024:Ligands; D019700:Thrombospondin 1; D015936:Complement C5a